about
Polymerized-type I collagen induces upregulation of Foxp3-expressing CD4 regulatory T cells and downregulation of IL-17-producing CD4⁺ T cells (Th17) cells in collagen-induced arthritis.Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study.Value of Biomarkers in the Prevention of Rheumatoid Arthritis.Environmental factors and hormones in the development of rheumatoid arthritis.Prevalence of premature ovarian failure in patients with systemic lupus erythematosus.New viral outbreaks: time for rheumatologists to get involved?The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.Age at natural menopause among patients with systemic lupus erythematosus.Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life.[Microbiota and inflammatory rheumatisms].Role of reproductive and menopausal factors in functional and structural progression of rheumatoid arthritis: results from the SCQM cohortIs the prevention of rheumatoid arthritis possible?Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritisAre cardiovascular events and mortality in patients with systemic lupus erythematosus predictable at diagnosis?Intestinal dysbiosis in RA development: difficulty of establishing causality. Response to: 'Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study' by InamoPeriodontal status correlates with anti-citrullinated protein antibodies in first-degree relatives of individuals with rheumatoid arthritisMenopause and Possible Effect on Association Between Age and Anticyclic Citrullinated Peptide Antibodies in Women At Risk of Rheumatoid ArthritisDrug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution
P50
Q35418181-A1C01C69-FBE3-4705-B242-6357EE8B60B5Q37309669-30854727-B6CC-4FA8-863D-F80CA1369BB7Q38655399-69FD3F84-AB78-45C7-A212-11E728B32664Q39268721-8752DA67-DE98-486F-9C98-B6064DE6421FQ40200817-88601AA7-9D96-46C1-89CF-CB3D51E8FB70Q40225114-DFEE2DC4-BA00-403A-912E-69472678E341Q40369679-5BE2A4A9-0D6A-464F-8A23-7327174C3DDDQ46554198-E293EA04-9487-43B0-B029-2F492ECA4328Q47778526-23BC8EEF-9DD1-42D1-8B68-4B8B7F5458A9Q52669860-1C7AB5CA-C0F6-4240-9E4F-B330BE9A319CQ58091744-915473B8-85A1-4C82-B158-3D835FE58F1AQ89523051-3CFFE657-5B66-4640-8821-CF05E227107CQ90355973-1A02C42D-E58C-42AE-950B-8C1908F3C64FQ91226465-4A492F8B-D1BE-479A-AA4B-57E960DA36E2Q91523889-5EFDCCEE-DB09-4B52-8FD4-02096A070C05Q91534386-0DDD0FC3-542B-43B6-B974-C66A3DE39811Q91581459-6AFCC43A-8FA6-4B28-B12D-8386F26B7354Q92827458-915070BE-972A-4D7C-8FC3-9C913FAD3F4B
P50
description
investigador
@es
researcher
@en
name
Deshiré Alpizar-Rodríguez
@en
type
label
Deshiré Alpizar-Rodríguez
@en
prefLabel
Deshiré Alpizar-Rodríguez
@en
P108
P108
P31
P496
0000-0002-6930-0517